Nuwellis (NUWE) Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Lumentum shares fall after hitting 52-week high
- Stryker invests $400M in CMR Surgical with option to acquire
Baxter International (BAX) PT Lowered to $40 at UBS
May 3, 2024 7:03 AM EDTUBS analyst Danielle Antalffy lowered the price target on Baxter International (NYSE: BAX) to $40.00 (from $42.00) while maintaining a Neutral rating.
The analyst comments "Our modestly lower $40 PT is derived by applying a ~12x P/E multiple to our Q5-Q8 sales estimate. Our... More
Baxter International (BAX) PT Lowered to $43 at Jefferies
May 2, 2024 3:59 PM EDTJefferies analyst Matthew Taylor lowered the price target on Baxter International (NYSE: BAX) to $43.00 (from $45.00) while maintaining a Hold rating.
The analyst comments "BAX reported 1Q24 sales of $3.59B +3% xfx vs cons $3.55B and EPS of $0.65 vs cons $0.61. BAX continues to... More



